Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

Captopril - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for captopril and what is the scope of freedom to operate?

Captopril
is the generic ingredient in seven branded drugs marketed by Hikma Intl Pharms, Vintage Pharms Llc, Sandoz, Teva, Dava Pharms Inc, Wockhardt, G And W Labs Inc, Mylan Pharms Inc, Apotex, Purepac Pharm, Par Pharm, Egis Pharms, Watson Labs, Apothecon, Prinston Inc, Stason, Ivax Sub Teva Pharms, and Mylan, and is included in thirty NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for captopril. Thirty suppliers are listed for this compound.

Summary for Generic Name: captopril

Tradenames:7
Patents:1
Applicants:18
NDAs:30
Drug Master File Entries: see list14
Suppliers / Packagers: see list30
Bulk Api Vendors: see list58
Clinical Trials: see list12
Patent Applications: see list8,366
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:captopril at DailyMed

Pharmacology for Ingredient: captopril

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon
CAPTOPRIL
captopril
TABLET;ORAL074472-002Mar 31, 1995DISCNNoNo► Subscribe► Subscribe
Egis Pharms
CAPTOPRIL
captopril
TABLET;ORAL074748-002May 29, 1997DISCNNoNo► Subscribe► Subscribe
Watson Labs
CAPTOPRIL
captopril
TABLET;ORAL074576-004Apr 23, 1996DISCNNoNo► Subscribe► Subscribe
G And W Labs Inc
CAPTOPRIL
captopril
TABLET;ORAL074433-004Feb 13, 1996DISCNNoNo► Subscribe► Subscribe
G And W Labs Inc
CAPTOPRIL
captopril
TABLET;ORAL074590-001Aug 30, 1996DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot